Corvus Pharmaceuticals to publish final Phase 1 data in Blood
Corvus Pharmaceuticals announced publication in Blood of final Phase 1 data from the Soquelitinib Phase 1/1b T cell lymphoma trial.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.